HomeCompareACUR vs GBDC

ACUR vs GBDC: Dividend Comparison 2026

ACUR yields 20000.00% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACUR wins by $52481917574412746752.00M in total portfolio value
10 years
ACUR
ACUR
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full ACUR calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — ACUR vs GBDC

📍 ACUR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACURGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACUR + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACUR pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACUR
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, ACUR beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACUR + GBDC for your $10,000?

ACUR: 50%GBDC: 50%
100% GBDC50/50100% ACUR
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

ACUR
Analyst Ratings
3
Buy
Consensus: Buy
Altman Z
-635.4
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACUR buys
0
GBDC buys
0
No recent congressional trades found for ACUR or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACURGBDC
Forward yield20000.00%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$52481917574412746752.00M$20.85M
Annual income after 10y$51,970,745,957,167,775,000,000,000.00$16,450,733.83
Total dividends collected$52448189483771600896.00M$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: ACUR vs GBDC ($10,000, DRIP)

YearACUR PortfolioACUR Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$2,010,700$2,000,000.00$12,492$1,791.70+$2.00MACUR
2$377,983,225$375,831,775.70$16,527$3,160.58+$377.97MACUR
3$66,433,479,469$66,029,037,418.28$23,588$5,904.90+$66433.46MACUR
4$10,916,985,471,987$10,845,901,648,955.73$37,141$11,901.65+$10916985.43MACUR
5$1,677,384,363,769,318$1,665,703,189,314,291.80$66,205$26,463.38+$1677384363.70MACUR
6$240,985,175,079,139,100$239,190,373,809,905,920.00$137,452$66,612.65+$240985175079.00MACUR
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$342,372$195,298.53+$32373573631143.35MACUR
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$1,053,292$686,954.33+$4066766648320629.00MACUR
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$4,111,439$2,984,416.95+$477730483406513344.00MACUR
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$20,849,974$16,450,733.83+$52481917574412746752.00MACUR

ACUR vs GBDC: Complete Analysis 2026

ACURStock

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.

Full ACUR Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this ACUR vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACUR vs SCHDACUR vs JEPIACUR vs OACUR vs KOACUR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.